Glucovance is a prescription medication combining metformin hydrochloride (500mg) and glibenclamide (5mg) in film-coated tablets. Manufactured by Merck, this combination therapy helps control blood sugar levels in patients with type 2 diabetes. Each package contains 30 tablets for oral use. The medication works through dual mechanisms - metformin reduces glucose production in the liver and improves insulin sensitivity, while glibenclamide stimulates insulin release from the pancreas. The film coating protects the active ingredients and makes the tablets easier to swallow. The product comes in Merck's distinctive white and red packaging with clear labeling in both English and Arabic. As a prescription medication, it should only be taken under medical supervision according to prescribed dosage.